Atopic Dermatitis (Eczema) Treatment: A Severity-Based Approach

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease causing intense itch, erythema, and barrier dysfunction. Management follows a stepwise algorithm based on severity, extent, and impact on quality of life.

Mild AD: Topical First‑Line

• Emollients: Fragrance‑free, ceramide‑rich moisturizers ≥2× daily (within 3 min of bathing) to repair barrier.
• Topical corticosteroids (TCS): Low‑to‑mid potency (e.g., hydrocortisone 2.5%, triamcinolone 0.1%) for flares, 1–2× daily for ≤2 weeks. Use fingertip units for dosing.
• Topical calcineurin inhibitors (TCI): Tacrolimus 0.03%/0.1%, pimecrolimus 1% for sensitive areas (face, folds) or steroid‑sparing maintenance. No atrophy risk.
• Crisaborole 2% ointment: PDE4 inhibitor for mild‑moderate AD; alternative to TCS/TCI.

Moderate‑to‑Severe AD: Systemic and Advanced Therapies

• Phototherapy: Narrowband UVB 2–3×/week; effective for widespread disease. Requires clinic access.
• Conventional systemics (off‑label, short‑term): Cyclosporine (rapid control), methotrexate, azathioprine, mycophenolate. Require monitoring (renal, hepatic, CBC).
• Biologics (targeted, FDA‑approved):
  • Dupilumab (anti‑IL‑4Rα): First biologic for AD (≥6 mo). Blocks IL‑4/IL‑13. Dramatic improvement in itch, lesions, QoL. Safety: conjunctivitis, injection reactions.
  • Tralokinumab (anti‑IL‑13): Alternative for adults inadequately controlled on TCS.
• JAK inhibitors (oral, FDA‑approved):
  • Upadacitinib, abrocitinib: Rapid, potent. For refractory moderate‑severe AD. Monitor CBC, lipids, LFTs, infections, thrombosis risk. Black box warning.

Severe/Refractory: Combination and Emerging Options

• TCS/TCI + phototherapy or systemic
• Biologic + TCS for residual lesions
• Clinical trials (e.g., anti‑IL‑31, anti‑OSM, microbiome therapies)

Essential Adjuncts for All Severities

• Trigger avoidance: Irritants (wool, fragrances), allergens (dust mite, pet), heat/sweat, stress.
• Bathing: Lukewarm, ≤10 min, gentle cleanser, pat dry, moisturize immediately.
• Bleach baths: ½ cup 6% bleach in full tub 2×/week for recurrent staph colonization.
• Wet wrap therapy: For severe flares; enhances topical penetration.
• Behavioral support: Habit reversal for scratching; CBT for sleep/stress.

Shared Decision‑Making

Partner with a dermatologist to balance efficacy, safety, cost, access, and patient preferences. Regular reassessment ensures optimal control and minimizes long‑term sequelae (lichenification, pigment changes, psychosocial burden).